Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Glucosamine sulfate + potassium chloride is a combination product commonly used as a dietary supplement and symptomatic therapy for osteoarthritis and other joint disorders. Glucosamine sulfate is a naturally occurring amino sugar vital for the synthesis of glycosaminoglycans, key components in cartilage formation and repair. Potassium chloride is included to stabilize the glucosamine sulfate, enhancing its stability and bioavailability. This combination acts as a chondroprotective agent by stimulating the synthesis of proteoglycans, which support the regeneration and maintenance of cartilage. Its primary action is to alleviate osteoarthritis symptoms by reducing joint pain, swelling, and slowing cartilage degradation. The formulation is not a steroid or NSAID and is not disease-modifying; effectiveness in clinical use remains debated. It is commonly marketed as a dietary supplement and may interact with blood-thinning, anti-diabetic, or chemotherapy medications. Safety in children and pregnancy is unproven[1][2][6].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on glucosamine sulfate + potassium chloride.